|
|||||
|
|
Management of immunotherapy colitis: Special considerations in the COVID-19 era |
|
| Authors: | Shilpa Grover MD MPH Sheila A. Bond MD Michael K. Mansour MD PhD Sonia Friedman MD |
| Affiliation: | 1. Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;2. Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;3. Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts |
| Abstract: | |
| Keywords: | |